CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer

NCT06281405 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer
Neoadjuvant Therapy

Interventions

DRUG: PD-1 inhibitor
DRUG: Capecitabine
RADIATION: Short-course radiotherapy
DRUG: Oxaliplatin

Sponsor

Fudan University